HPV vaccination in Germany: only a missed opportunity in cancer prevention or a symptom of structural weakness?

Benedikt MJ Lampl

Open source

DOI
10.1016/j.healthpol.2026.105816
Published
2027-02
Container
Health Policy
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.healthpol.2026.105816,
  title = {HPV vaccination in Germany: only a missed opportunity in cancer prevention or a symptom of structural weakness?},
  author = {Benedikt MJ Lampl},
  year = {2027},
  journal = {Health Policy},
  doi = {10.1016/j.healthpol.2026.105816},
  url = {https://doi.org/10.1016/j.healthpol.2026.105816}
}

RIS

TY  - JOUR
TI  - HPV vaccination in Germany: only a missed opportunity in cancer prevention or a symptom of structural weakness?
AU  - Benedikt MJ Lampl
PY  - 2027
JO  - Health Policy
DO  - 10.1016/j.healthpol.2026.105816
UR  - https://doi.org/10.1016/j.healthpol.2026.105816
ER  - 

APA

Lampl, B. M. (2027). HPV vaccination in Germany: only a missed opportunity in cancer prevention or a symptom of structural weakness?. Health Policy. https://doi.org/10.1016/j.healthpol.2026.105816

Source records